« Not All Bruton’s Tyrosine Kinase Inhibitors Are Created Equal: Pharmacologic Insights into the Efficacy, Resistance, and Safety of Covalent and Non-Covalent BTK Inhibitors ». 2026. Actualité hématologique Au Canada 5 (s02): 2–7. https://doi.org/10.58931/cht.2026.5s0282.